Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 1
1978 1
1980 1
1986 1
2008 1
2012 1
2013 1
2014 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Drugs for atopic dermatitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96. Med Lett Drugs Ther. 2020. PMID: 32555122 No abstract available.
Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis.
Conde JF, Kaur M, Fleischer AB Jr, Tusa MG, Camacho F, Feldman SR. Conde JF, et al. Cutis. 2008 May;81(5):435-41. Cutis. 2008. PMID: 18543596 Clinical Trial.
The purpose of this study was to determine both self-reported and actual adherence to clocortolone pivalate cream 0.1% in the treatment of AD in a pediatric population. ...While some patients are adherent to treatment, others rapidly discontinue their use of medication ove …
The purpose of this study was to determine both self-reported and actual adherence to clocortolone pivalate cream 0.1% in the treatme …
The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
Kircik LH, Del Rosso JQ. Kircik LH, et al. J Drugs Dermatol. 2012 Oct;11(10):1194-8. J Drugs Dermatol. 2012. PMID: 23134984 Clinical Trial.
OBJECTIVE: Study results evaluating the efficacy and safety of clocortolone pivalate 0.1% cream in the treatment of adults, young children, and infants with inflammatory facial dermatoses are reported in this article. ...METHODS: Clocortolone pivalate 0.01% cream wa …
OBJECTIVE: Study results evaluating the efficacy and safety of clocortolone pivalate 0.1% cream in the treatment of adults, young chi …
A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
Kircik LH. Kircik LH. J Drugs Dermatol. 2014 May;13(5):582-5. J Drugs Dermatol. 2014. PMID: 24809882 Clinical Trial.
These studies showed that clocortolone pivalate cream enhances barrier function by providing occlusion. ...In this regard, these studies were designed to determine the hydrating effects of clocortolone pivalate cream 0.1% (Cloderm Cream, Promius Pharma)....
These studies showed that clocortolone pivalate cream enhances barrier function by providing occlusion. ...In this regard, these stud …
Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.
Del Rosso JQ, Kircik LH. Del Rosso JQ, et al. J Drugs Dermatol. 2014 Jul;13(7):s77-83. J Drugs Dermatol. 2014. PMID: 25007376
As many topical products eventually become available as generic formulations, it is important to recognize that although the active ingredient and its concentration are the same, the vehicle excipients may differ significantly, occasionally leading to potential differences in irr …
As many topical products eventually become available as generic formulations, it is important to recognize that although the active ingredie …
The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream.
Del Rosso JQ, Kircik LH. Del Rosso JQ, et al. J Drugs Dermatol. 2013 Feb;12(2):s5-s10. J Drugs Dermatol. 2013. PMID: 23377405
There are several commercially available products in this category, and many vehicles and formulations for the clinician to choose from. Clocortolone pivalate 0.1% cream is a midpotency TCS formulated in an emollient formulation that has been shown to be effective and well …
There are several commercially available products in this category, and many vehicles and formulations for the clinician to choose from. …
[Human-pharmacokinetic Studies on Penetration Kinetics of a 6 alpha-Fluoro-9 alpha-chloro-16 alpha-methyl-delta 1,4-pregnadiene-11 beta-dihydroxy-3,20-dione-21-trimethyl-acetic acid (Clocortolone Trimethyl-acetic acid) after e picutaneous application].
Kolb KH, Latza R, Hepp-Latza O, Lücker PW, Rindt W, Simon B. Kolb KH, et al. Arzneimittelforschung. 1978;28(9):1648-51. Arzneimittelforschung. 1978. PMID: 582571 German.
Investigation on 6 alpha-fluoro-9 alpha-chloro-16 alpha-methyl-delta 1,4-pregnadiene-11 beta-dihydroxy-3,20-dione-21-trimethylacetic acid (clocortolone trimethylacetic acid) are reported. The aim of the trial was to prove the penetration kinetics of the steriod into the sk …
Investigation on 6 alpha-fluoro-9 alpha-chloro-16 alpha-methyl-delta 1,4-pregnadiene-11 beta-dihydroxy-3,20-dione-21-trimethylacetic acid ( …
Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis.
Rosenthal AL. Rosenthal AL. Cutis. 1980 Jan;25(1):96-8. Cutis. 1980. PMID: 6986236 Clinical Trial.
One hundred patients with eczema/atopic dermatitis were treated in a double-blind, paired-comparison fashion with clocortolone pivalate 0.1 percent cream and the placebo cream base. Results with the active agent were statistically significantly superior in all objective an …
One hundred patients with eczema/atopic dermatitis were treated in a double-blind, paired-comparison fashion with clocortolone pivala …
[Development and regression of dermal corticosteroid atrophy. 1. Change in the skinfold thickness].
Lubach D, Hinz E. Lubach D, et al. Derm Beruf Umwelt. 1986 Sep-Oct;34(5):146-9. Derm Beruf Umwelt. 1986. PMID: 2947794 German.
Clobetasol-17-propionate, betamethanone-17-valerate, diflorasone-17,21-diacetate, triamcinolane acetonide, hydrocortisone (in 10% urea), hydrocortisone butyrate and a mixture of clocortolone-21-pivalate and clocortolone-21-hexynoate were tested. The steroid products …
Clobetasol-17-propionate, betamethanone-17-valerate, diflorasone-17,21-diacetate, triamcinolane acetonide, hydrocortisone (in 10% urea), hyd …
12 results